InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,299.17
(
1.00%
)
US TECH 100
18,098.40
(
1.46%
)
Dow Jones
39,819.98
(
0.66%
)
Brent Oil
82.57
(
0.02%
)
Bitcoin
65,389.36
(
6.24%
)
Post# of 251825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: ghmm post# 162822

Friday, 06/21/2013 4:40:20 AM

Friday, June 21, 2013 4:40:20 AM

Post# of 251825
PLX

The recombinant AAT sounds interesting too.

Note that PLX is going for inhaled formulation and they will know the results from KMDA's phase II/III of inhaled AAT in the same indication by early 2014. Interesting also since Kamada has an orphan drug designation in both EU and US.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up